Table 2.
Diagnoses in 2598 patients who underwent at least one pituitary MRI from January 1999 to November 2010
| Diagnoses | Total | Number of masses, [age range], and (average age), at initial pituitary MRIa |
Newly diagnosedb | Pathologyc | |
|---|---|---|---|---|---|
| Males | Females | ||||
| Anterior pituitary tumors | |||||
| Prolactinoma | 395 | 90 [17–81] (46) | 305 [15–89] (36) | 182 | 54 |
| Nonfunctioning adenoma | 364 | 162 [18–85] (54) | 202 [17–87] (47) | 166 | 164 |
| GH adenoma | 127 | 59 [19–84] (49) | 68 [18–82] (45) | 31 | 43 |
| ACTH adenoma | 84 | 18 [19–77] (43) | 66 [10–66] (38) | 47 | 34 |
| GH/prolactin mixed adenoma | 4 | 3 [24–42] (32) | 1 [15] | 1 | 4 |
| Nelson's syndrome | 2 | 0 [24–42] (30) | 2 [44–66] (50) | 1 | 0 |
| Pituitary carcinomad | 2 | 2 [45–75] (60) | 0 | 2 | 2 |
| LH/FSH functioning adenoma | 1 | 1 [59] | 0 | 0 | 1 |
| TSH adenoma | 1 | 0 | 1 [31] | 1 | 1 |
| GH/TSH mixed adenoma | 1 | 0 | 1 [35] | 1 | 0 |
| Cysts | |||||
| Rathke's cleft cyst | 42 | 12 [14–75] (40) | 30 [2–68] (40) | 35 | 25 |
| Craniopharyngioma | 33 | 13 [1–54] (29) | 20 [8–73] (45) | 12 | 20 |
| Arachnoid | 2 | 2 [33–56] (45) | 0 | 0 | 1 |
| Epidermoid | 1 | 0 | 1 [67] | 1 | 1 |
| Pineal cyst | 1 | 1 [11] | 0 | 1 | 0 |
| Nonadenomatous neoplasms | |||||
| Meningioma | 32 | 7 [28–81] (52) | 25 [33–89] (64) | 15 | 13 |
| Chordoma | 3 | 3 [24–69] (43) | 0 | 1 | 3 |
| Pituitary lymphoma | 2 | 1 [48] | 1 [81] | 2 | 2 |
| Chondrosarcoma | 1 | 0 | 1 [24] | 1 | 1 |
| Embryonal rhabdomyosarcoma | 1 | 0 | 1 [10] | 0 | 1 |
| Germinoma | 1 | 1 [12] | 0 | 1 | 1 |
| Granular cell tumor | 1 | 0 | 1 [53] | 0 | 1 |
| Hemangiopericytoma, malignant | 1 | 0 | 1 [77] | 1 | 1 |
| Leiomyosarcoma | 1 | 0 | 1 [36] | 1 | 1 |
| Mucoepidermoid carcinoma | 1 | 0 | 1 [40] | 0 | 1 |
| Pituicytoma | 1 | 1 [38] | 0 | 0 | 1 |
| Xanthogranuloma | 1 | 1 [25] | 0 | 1 | 1 |
| Inflammatory and vasculitidies | |||||
| Lymphocytic hypophysitis | 3 | 1 [45] | 2 [26–34] (30) | 1 | 2 |
| Hypophysitis, unspecified type | 2 | 0 | 2 [37–54] (46) | 0 | 0 |
| Lymphocytic infundibulitis | 1 | 0 | 1 [29] | 0 | 1 |
| Amyloidosis, primary | 1 | 0 | 1 [54] | 1 | 0 |
| Sarcoidosis | 1 | 1 [37] | 0 | 0 | 0 |
| Wegener's granulomatosis | 1 | 1 [44] | 0 | 1 | 1e |
| Infectious | |||||
| Pseudomonas aeruginosa | 1 | 1 [40] | 0 | 1 | 1 |
| Syphilis | 1 | 1 [38] | 0 | 1 | 0 |
| Metastases | |||||
| Breast | 3 | 0 | 3 [32–69] (52) | 3 | 1 |
| CNS lymphoma, to pituitary stalk | 1 | 1 | 0 [72] | 1 | 1 |
| Nasopharyngeal lymphoma | 1 | 0 | 1 [44] | 1 | 1 |
| Liver epitheliod hemangioendothelioma | 1 | 1 [51] | 0 | 0 | 1 |
| Lung, adenocarcinoma | 1 | 1 [71] | 0 | 1 | 0 |
| Pineal germinoma/dysgerminoma | 1 | 1 [18] | 0 | 1 | 1 |
| Plasmacytoma | 1 | 1 [60] | 0 | 1 | 1 |
| Prostate, adenocarcinoma | 1 | 1 [59] | 0 | 1 | 1 |
| Sinusoidal squamous cell carcinoma | 1 | 0 | 1 [70] | 1 | 1 |
| Vascular | |||||
| Apoplexy with masses | 16 | 9 [37–70] (54) | 7 [23–88] (50) | 13 | 9 |
| Carotid aneurysm | 4 | 2 [57–78] (68) | 2 [41–86] (64) | 4 | n/a |
| Hypothalamic cavernous angioma | 1 | 0 | 1 [38] | 1 | 0 |
| Hypothalamic interpeduncular hematoma | 1 | 1 [31] | 0 | 1 | 1 |
| Miscellaneous | |||||
| Empty sella | 21 | 5 [18–48] (36) | 16 [32–62] (47) | 16 | n/a |
| Hyperplasia | 14 | 0 | 14 [14–58] (40) | 10 | 11 |
| Ectopic pituitary gland | 4 | 2 [14 days–25] (12) | 2 [17–67] (42) | 4 | 0 |
| Fibrous dysplasia | 3 | 0 | 3 [26–67] (47) | 1 | 2 |
| Lipoma | 1 | 0 | 1 [23] | 1 | 0 |
| Hypothalamic | |||||
| Astrocytoma | 2 | 0 | 2 [13–37] (25) | 1 | 1 |
| Germinoma | 1 | 1 [26] | 0 | 0 | 0 |
| Hamartoma | 1 | 0 | 1 [10] | 0 | 0 |
| Undiagnosed masses | 159 | 48 [15–93] (48) | 111 [10–89] (43) | n/a | 5f |
| Normal pituitary | 1242 | 436 [2 months–88] (44) | 806 [2–91] (39) | n/a | 21 |
n/a, Not applicable.
Age specified in years, unless otherwise noted. Age range and average noted if applicable;
masses diagnosed after initial pituitary MRI; includes undiagnosed incidentalomas;
number of pathological reports available at this institution to confirm diagnoses;
two cases of pituitary carcinomas initially diagnosed as prolactinomas, which changed at time of biopsy after initial pituitary MRI;
pathology confirmed by serological tests;
five patients with nondiagnostic pathology results.